Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab

Detalles Bibliográficos
Autores principales: Freeman, C L, Dixon, M, Houghton, R, Kreuzer, K-A, Fingerle-Rowson, G, Herling, M, Humphrey, K, Böttcher, S, de Costa, C S, Iglesias, V, Stilgenbauer, S, Gribben, J, Hallek, M, Goede, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980557/
https://www.ncbi.nlm.nih.gov/pubmed/26979130
http://dx.doi.org/10.1038/leu.2016.41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980557/
https://www.ncbi.nlm.nih.gov/pubmed/26979130
http://dx.doi.org/10.1038/leu.2016.41

Ejemplares similares